热门出版物 - 学术资源搜索

h5 指数:52
h5 中位数:87

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#5 Transplantation
#15 Hematology

标题/作者	引用次数	年份
Mesenchymal stem cell-derived exosomes for clinical use M Mendt, K Rezvani, E Shpall Bone Marrow Transplantation 54 (Suppl 2), 789-792	318	2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 RF Duarte, M Labopin, P Bader, GW Basak, C Bonini, C Chabannon, ... Bone Marrow Transplantation 54 (10), 1525-1552	276	2019
EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment HM Schoemans, SJ Lee, JL Ferrara, D Wolff, JE Levine, KR Schultz, ... Bone Marrow Transplantation 53 (11), 1401-1415	263	2018
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, JH Dalle, ... Bone Marrow Transplantation 53 (2), 138-138	250	2018
Early and late hematologic toxicity following CD19 CAR-T cells S Fried, A Avigdor, B Bielorai, A Meir, MJ Besser, J Schachter, A Shimoni, ... Bone Marrow Transplantation 54 (10), 1643-1650	248	2019
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy P Ljungman, M Mikulska, R de la Camara, GW Basak, C Chabannon, ... Bone Marrow Transplantation 55 (11), 2071-2076	202	2020
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years JR Passweg, H Baldomero, C Chabannon, GW Basak, R de la Cámara, ... Bone Marrow Transplantation 56 (7), 1651-1664	201	2021
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors J Styczyński, G Tridello, L Koster, S Iacobelli, A van Biezen, ... Bone Marrow Transplantation 55 (1), 126-136	186	2020
Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians J Gauthier, QV Wu, TA Gooley Bone Marrow Transplantation 55 (4), 675-680	184	2020
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation SO Ciurea, K Cao, M Fernandez-Vina, P Kongtim, MA Malki, E Fuchs, ... Bone Marrow Transplantation 53 (5), 521-534	181	2018
Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report JR Passweg, H Baldomero, P Bader, GW Basak, C Bonini, R Duarte, ... Bone Marrow Transplantation 53 (9), 1139-1148	179	2018
COVID-19 outcomes in patients with hematologic disease F Malard, A Genthon, E Brissot, Z van de Wyngaert, Z Marjanovic, S Ikhlef, ... Bone Marrow Transplantation 55 (11), 2180-2184	177	2020
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies JR Passweg, H Baldomero, GW Basak, C Chabannon, S Corbacioglu, ... Bone Marrow Transplantation 54 (10), 1575-1585	171	2019
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati A Balduzzi, E Brivio, A Rovelli, C Rizzari, S Gasperini, ML Melzi, V Conter, ... Bone Marrow Transplantation 55 (10), 1900-1905	157	2020
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus JR Passweg, H Baldomero, C Chabannon, GW Basak, S Corbacioglu, ... Bone Marrow Transplantation 55 (8), 1604-1613	155	2020
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE) B Sharrack, R Saccardi, T Alexander, M Badoglio, J Burman, D Farge, ... Bone Marrow Transplantation 55 (2), 283-306	143	2020
Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) S Giebel, DI Marks, N Boissel, F Baron, S Chiaretti, F Ciceri, ... Bone Marrow Transplantation 54 (6), 798-809	114	2019
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation SO Ciurea, MM Al Malki, P Kongtim, EJ Fuchs, L Luznik, XJ Huang, ... Bone Marrow Transplantation 55 (1), 12-24	111	2020
Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL VS Sheth, J Gauthier Bone Marrow Transplantation 56 (3), 552-566	110	2021
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement WI Gonsalves, FK Buadi, S Ailawadhi, PL Bergsagel, AA Chanan Khan, ... Bone Marrow Transplantation 54 (3), 353-367	105	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。